Semmax Financial Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$6.15K	Hold	14	–	–	﹤0.01%	286
2025 Q1	$3.52K	Hold	14	–	–	﹤0.01%	298
2024 Q4	$3.71K	Hold	14	–	–	﹤0.01%	270
2024 Q3	$3.77K	Hold	14	–	–	﹤0.01%	265
2024 Q2	$3.75K	Hold	14	–	–	﹤0.01%	298
2024 Q1	$2.1K	Hold	14	–	–	﹤0.01%	301
2023 Q4	$2.27K	Hold	14	–	–	﹤0.01%	306
2023 Q3	$2.31K	Buy	+14	New	+$2.67K	﹤0.01%	269
2022 Q4	$3K	Hold	14	–	–	﹤0.01%	218
2022 Q3	$3K	Sell	14 -807	-98%	-$154K	﹤0.01%	208
2022 Q2	$190K	Sell	821 -100	-11%	-$14.2K	0.08%	91
2022 Q1	$150K	Sell	921 -72	-7%	-$11K	0.06%	107
2021 Q4	$168K	Sell	993 -189	-16%	-$35.1K	0.06%	108
2021 Q3	$223K	Sell	1,182 -138	-10%	-$25.9K	0.08%	102
2021 Q2	$224K	Buy	1,320 +19	+1%	+$2.78K	0.07%	104
2021 Q1	$184K	Buy	+1,301	New	+$196K	0.07%	103